Panadol ActiFast Soluble tablets

Riik: Suurbritannia

keel: inglise

Allikas: MHRA (Medicines & Healthcare Products Regulatory Agency)

Osta kohe

Laadi alla Infovoldik (PIL)
05-01-2023
Laadi alla Toote omadused (SPC)
20-10-2022

Toimeaine:

Paracetamol

Saadav alates:

Haleon UK Ltd

ATC kood:

N02BE01

INN (Rahvusvaheline Nimetus):

Paracetamol

Annus:

500mg

Ravimvorm:

Effervescent tablet

Manustamisviis:

Oral

Klass:

No Controlled Drug Status

Retsepti tüüp:

Valid as a prescribable product

Toote kokkuvõte:

BNF: 04070100; GTIN: 5000347033476

Toote omadused

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Panadol ActiFast Soluble Tablets
Or
Panadol Soluble 500 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Paracetamol Ph.Eur. 500.0 mg
3
PHARMACEUTICAL FORM
Effervescent tablet (Tablets).
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Paracetamol
is
a
mild
analgesic
and
antipyretic,
and
is
recommended
for
the
treatment of most painful and febrile conditions, for example,
headache including
migraine and tension headaches, toothache, backache, rheumatic and
muscle pains,
dysmenorrhoea, sore throat, and for relieving the fever, aches and
pains of colds and
flu.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Adults, the elderly, and children aged 16 years and over:
1 -2 tablets in at least half a tumbler of water, up to 4 times daily
as required.
Children:
Aged 10-15 years: 1 tablet dissolved in water up to 4 times daily.
Not recommended for children under the age of 10 years.
Children should not be given paracetamol for more than 3 days without
consulting a
doctor.
Doses of paracetamol should not be given more frequently than every 4
hours, and
not more than 4 doses should be given in any 24 hour period.
Oral administration only.
4.3
CONTRAINDICATIONS
Hypersensitivity to paracetamol or any of the other constituents.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Contains paracetamol. Do not use with any other paracetamol-containing
products.
Underlying liver disease increases the risk or paracetamol related
liver damage.
Patients who have been diagnosed with liver or kidney impairment must
seek medical
advice before taking this medication.
Do not exceed the stated dose.
Patients should be advised to consult their doctor if their headaches
become
persistent.
Patients should be advised to consult a doctor if they suffer from
non-serious arthritis
and need to take painkillers every day.
Each soluble tablet contains 427 mg of sodium per tablet (854 mg of
sodium per 2
tablet dose). To be taken into consideration by patients on a
con
                                
                                Lugege kogu dokumenti